首頁 > 市場調查報告書 > 醫療設備

e保健醫學影像診斷超音波

市場調查報告書

商品編碼

1372610

2023-2030 年全球攜帶式靜脈查找儀市場

Global Portable Vein Finder Market 2023-2030

出版日期: 2023年10月18日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球攜帶式靜脈查找器市場於 2022 年達到 100 萬美元，預計到 2030 年將達到 100 萬美元，在 2023-2030 年預測期內年複合成長率為 100%。

攜帶式靜脈查找器透過顯示患者皮膚上靜脈的即時影像來定位靜脈。靜脈查找器通常不是攜帶式的，但攜帶式靜脈查找器在醫院環境中為不同患者進行靜脈穿刺技術時很容易隨身攜帶。這些也稱為靜脈照明器，因為它們使用透射照明技術來觀察皮膚表面的靜脈。

靜脈觀察器可提高準確性、最大程度地減少不適並降低靜脈穿刺的風險。抽血醫師主要使用靜脈觀察器來幫助定位靜脈進行抽血，從而提高手術的成功率。靜脈偵測器可減少併發症、提高病患滿意度並提高首次嘗試的成功率。

市場動態：促進因素與限制因素

增加住院人數

疫情期間住院和定期醫療檢查的人數增加。人們對健康意識的不斷增強使得人們定期去看醫生。靜脈探查器用於為患者抽血、靜脈穿刺等，對患者進行診斷、監測、治療等目的。住院人數的增加增加了靜脈偵測器的使用，進一步推動了市場的發展。

例如，根據美國醫院協會的數據，2023 年，根據 6,200 多家醫院和 400 個醫療保健系統提供的資料，美國所有醫院的入院總人數為 34,011,386 人。

此外，根據世界衛生組織的數據，2023年，在全球範圍內，過去28天內（2023年8月至9月），共有95 999例新增住院病例和985例新增ICU入院病例，增加了42 %，與前 28 天（2023 年 7 月至 8 月）相比分別成長了 12%。

根據澳洲健康與福利研究所的數據，2023年，2021-22年公立和私立醫院入院人數為1,160萬人，較上年下降2.1%。在此之前，2019-20 年至 2020-21 年成長了 6.3%。

首次嘗試在深色皮膚人群中失敗

中度或深色膚色的患者首次靜脈注射 PIV 導管插入的成功率為 57%，而淺膚色患者的成功率為 78%。深色或中等膚色患者的成功率接近57.1%，比淺膚色患者的成功率（78%）低21%。據 Accuvein 稱，深色皮膚色素沉著患者的首次嘗試失敗率高達 21%。靜脈偵測器在暗色和深色膚色上不太可行，因為在深色膚色的人中看不到照明光。

有關此報告的更多詳細資訊 - 索取樣品

Portable vein finder locates veins by showing real-time images of veins on the patient's skin. Vein finders are not often portable, but portable ones are easy to carry around during the venipuncture techniques for different patients in hospital settings. These are also called vein illuminators, as they use trans-illumination technology to view the veins on the skin's surface.

Vein viewers enhance accuracy, minimize discomfort, and reduce the risk of venipunctures. Phlebotomists mainly use vein viewers to help locate veins for blood draws, which improves the procedure's success rate. Vein finders reduce complications, increase patient satisfaction, and increase first-attempt success.

Market Dynamics: Drivers & Restraints

Increasing hospital admissions

The number of hospitalizations and regular healthcare checkups increased during the pandemic. The growing awareness about health among people is making people regularly visit doctors. Vein finders are used for patients to draw blood, venipuncture, etc., which is done to patients for diagnosis, monitoring, and treatment purposes. Increased hospital admissions increase the use of vein finders, further driving the market.

For instance, according to the American Hospital Association, 2023, per the data provided by over 6,200 hospitals and 400 healthcare systems, total admissions in all U.S. hospitals are 34,011,386.

Furthermore, according to the World Health Organization, 2023, At the global level, during the past 28 days (August to September 2023), a total of 95 999 new hospitalizations and 985 new ICU) admissions were reported, an increase of 42% and 12% respectively, compared to the previous 28 days (July to August 2023).

According to the Australian Institute of Health and Welfare, 2023, there were 11.6 million public and private hospital admissions in 2021-22, a 2.1% decrease from the previous year. This followed a 6.3% increase from 2019-20 to 2020-21.

First attempt failure in dark-skinned people

Patients with medium or dark skin color had a first IV attempt success rate of 57% for PIV catheter insertions, while fair skin color patients had a rate of 78%. The success rate for patients with dark or medium skin color was nearly 57.1%, which was 21% less than the success rate for those with light skin color (78%). According to Accuvein, the first stick attempt failure rate is up to 21% higher in patients with dark skin pigmentation. Vein finders are not so feasible on dusky and dark skin tones because the illuminated light is not visible in dark-skin-toned people.

For more details on this report - Request for Sample

Segment Analysis

The global portable vein finder is segmented based on product type, technology, end-user and region.

The transillumination segment accounted for approximately 47.3% of the market share

Transillumination uses light to illuminate the veins. The image is due to deoxyhemoglobin in the venous blood, which absorbs red light and radiates the veins as dark lines on the skin's surface. This is the easiest and most reliable way of accessing the vein on the skin's surface. Launching the vein finders using transillumination technology makes the work of clinicians easy due to its efficiency.

In April 2022, ImmunoTek Bio Centers launched the first blood plasma collection centers using VeinViewer, developed by Christie Medical Holdings, which provides phlebotomists with real-time images of the donor's veins before needle insertion.

In September 2021, NextVein LLC launched a product that makes vein visualization affordable for every clinician. The NextVein system is designed from the ground up to be a simple-to-use, cost-effective solution for successful vein access.

Geographical Analysis

North America accounted for approximately 40.2% of the market share in 2022

Hospital admissions in the U.S. increased drastically in 2021; there were over 34 million hospital admissions in the United States. The number of hospitals in the U.S. has decreased in recent years, although the country faces an increasing elderly population. Predictably, the elderly account for the largest share of hospital admissions in the U.S.

For instance, according to the report published in 2023 by the Centers for Disease Control and Prevention (CDC), the total number of hospitalizations from COVID-19, flu, and syncytial virus infections this year, similar to last year, higher than pre-pandemic levels.

Although COVID-19 hospitalizations have drastically decreased since 2022, there is an increase in awareness about healthcare checkups after the pandemic. Moreover, there is an increased geriatric population in the United States and the rest of the world; hence, North America holds the largest share of the market.

COVID-19 Impact Analysis:

COVID-19 created a surge in the portable vein finder market. The number of patients visiting hospitals increased during the pandemic, which increased the use of hospital equipment and medical devices. Vein finders allow physicians to access veins easily within less time, which is less time-consuming than manually finding them on patients' skin. For almost all patients, these medical devices are used to access the vein quickly. This has increased the demand for portable vein finders during the pandemic period.

Competitive Landscape

The major global players in the portable vein finder market include: AccuVein, Inc, Christie Medical Holdings Inc., Novarix, TransLite, Vuetek, AMBULANC (SHENZHEN) TECH. CO. LTD.ZD Medical, BLZ Technology, B. Braun Medical Inc., ThermoFisher Scientific Inc, Delta Medical International Ltd among others.

Key Developments

In October 2022, Right Way Medical, a medical device distributor is in partnership with NextVein, to increase patient satisfaction. It uses augmented reality to project the vein pattern on patient skin, bringing clarity and simplicity to clinicians.

Why Purchase the Report?

To visualize the global portable vein finder market segmentation based on product type, technology, end-user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of portable vein finder market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global portable vein finder market report would provide approximately 61 tables, 51 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. Increasing hospital admissions
  - 4.1.1.2.
- 4.1.2. Restraints
  - 4.1.2.1. First attempt failure in dark-skinned people
  - 4.1.2.2.
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Display type*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Non-Display Type

8. By Technology

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
8.2. Near-infrared*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Visible light trans illumination
8.4. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic centers and Research Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. AccuVein, Inc
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Christie Medical Holdings Inc.
12.3. Novarix
12.4. TransLite
12.5. Vuetek
12.6. AMBULANC (SHENZHEN) TECH. CO. LTD.ZD Medical
12.7. BLZ Technology
12.8. B. Braun Medical Inc.
12.9. Thermo Fisher Scientific Inc
12.10. Delta Medical International Ltd